title: Technetium-99m-tetrofosmin myocardial imaging in cardiotoxicity screening for left-sided breast cancer irradiation.
authors.forename: Kiki
authors.initials: K
authors.lastname: Pistevou-Gompaki
authors.forename: Damianos
authors.initials: D
authors.lastname: Eleftheriadis
authors.forename: Christos
authors.initials: C
authors.lastname: Trontzos
authors.forename: Michael
authors.initials: M
authors.lastname: Goutzioulis
authors.forename: Vassilis
authors.initials: V
authors.lastname: Kouloulias
authors.forename: Nikos
authors.initials: N
authors.lastname: Eleftheriadis
authors.forename: Ioannis
authors.initials: I
authors.lastname: Sofroniadis
mesh_terms: D001943:Breast Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D003327:Coronary Disease / Q000000981:diagnostic imaging*; D004452:Echocardiography; D004562:Electrocardiography; D005260:Female; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D008875:Middle Aged; D009367:Neoplasm Staging; D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D011878:Radiotherapy / Q000009:adverse effects*
chemical_list: D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; C078700:technetium tc-99m tetrofosmin